bw a1433u has been researched along with n-formylmethionine leucyl-phenylalanine in 1 studies
Studies (bw a1433u) | Trials (bw a1433u) | Recent Studies (post-2010) (bw a1433u) | Studies (n-formylmethionine leucyl-phenylalanine) | Trials (n-formylmethionine leucyl-phenylalanine) | Recent Studies (post-2010) (n-formylmethionine leucyl-phenylalanine) |
---|---|---|---|---|---|
26 | 0 | 0 | 6,716 | 53 | 356 |
Protein | Taxonomy | bw a1433u (IC50) | n-formylmethionine leucyl-phenylalanine (IC50) |
---|---|---|---|
fMet-Leu-Phe receptor | Homo sapiens (human) | 0.02 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carper, HT; Hewlett, EL; Hylton, JB; Linden, J; Mandell, GL; Sullivan, GW | 1 |
1 other study(ies) available for bw a1433u and n-formylmethionine leucyl-phenylalanine
Article | Year |
---|---|
Adenosine and related compounds counteract tumor necrosis factor-alpha inhibition of neutrophil migration: implication of a novel cyclic AMP-independent action on the cell surface.
Topics: Actins; Adenosine; Adenosine Deaminase; Cell Movement; Chemotaxis, Leukocyte; Cyclic AMP; Humans; In Vitro Techniques; N-Formylmethionine Leucyl-Phenylalanine; Pentoxifylline; Receptors, Purinergic; Recombinant Proteins; Tumor Necrosis Factor-alpha; Xanthines | 1990 |